Background: The aetiology of systemic lupus erythematosus (SLE) remains unclear. Clinical observations and a small number of studies performed so far suggest an association between psychological stress and self-reported symptoms of SLE patients. This longitudinal study was designed to investigate whether daily psychological stress is associated with flares in SLE patients, measured by clinical and laboratory parameters. Methods: Female SLE patients (n = 41) were followed over a period of six months. Daily stress was monitored by a hand-held PC diary programmed with 44 items based on standardized measures and clinical experience. Once every four weeks patients visited the outpatient clinic for medical evaluation. Disease activity was evaluated using the European Consensus Lupus Activity Measurement (ECLAM), laboratory parameters, and intake of steroids. Results: Classification and regression tree (CART) patient-wise analyses revealed that SLE patients with vs. without flares using complement and ECLAM as activity measures show greater negative self-ratings in mood, and social duties (p < 0.01). In addition, mixed model analysis of variance showed that daily hassles with social relationships were significantly associated with flares in SLE measured by an increase in steroid medication >5mg/d (p < 0.01). Conclusions: These results suggest that psychological stress is associated with flares in SLE. Particularly daily stress with social relationships and social duties may be factors to be related to the course of disease activity in SLE.

Keywords:
Systemic lupus erythematosus, Autoimmunity, Daily stress, Social relationships, Disease activity, Flare, Hand-held PC, Longitudinal study, Classification and regression tree, MIXED model
1.
Adams SG Jr, Dammers PM, Saia TL, Brantley PJ, Gaydos GR: Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus. J Behav Med 1994;17:459–477.
2.
Wekking EM, Vingerhoets AJ, van Dam AP, Nossent JC, Swaak AJ: Daily stressors and systemic lupus erythematosus: A longitudinal analysis – first findings. Psychother Psychosom 1991;55:108–113.
3.
Wallace DJ, Metzger AL: Can an earthquake cause flares of rheumatoid arthritis or lupus nephritis? Arthritis Rheum 1994;37:1826–1828.
4.
Pawlak CR, Jacobs R, Mikeska E, Ochsmann S, Lombardi MS, Kavelaars A, Heijnen, CJ, Schmidt RE, Schedlowski M: Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress. Brain Behav Immun 1999;13:287–302.
5.
Jacobs R, Pawlak CR, Mikeska E, Meyer-Olson D, Martin M, Heijnen CJ, Schedlowski M, Schmidt RE: Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology 2001;40:868–875.
6.
Schmid-Ott G, Jacobs R, Jäger B, Klages S, Wolf J, Werfel T, Kapp A, Schürmeyer T, Lamprecht F, Schmidt RE, Schedlowski M: Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. Psychother Psychosom 1998;67:37–42.
7.
Fahrenberg J, Myrtek M (eds.): Progress in Ambulatory Assessment: Computer-Assisted Psychological and Psychophysiological Methods in Monitoring and Field Studies. Seattle, Hogrefe & Huber, 2001.
8.
DeLongis A, Folkman S, Lazarus RS: The impact of daily stress on health and mood: Psychological and social resources as mediators. J Pers Soc Psychol 1988;54:486–495.
9.
McNair DM, Lorr M, Doppleman LF: EITS Manual for the Profile of Mood States. SanDiego, Educational and Industrial Testing Service, 1971.
10.
Petri M, Buyon J, Kim M: Classification and definition of major flares in SLE clinical trials. Lupus 1999;8:685–691.
11.
Mirzayan MJ, Schmidt RE, Witte T: Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology 2000;39:1316–1319.
12.
Borg EJ ter, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990;33:634–643.
13.
Zonana-Nacach A, Salas M, Lourdes Sanchez MD, Camargo-Coronel A, Bravo-Gatica C, Mintz G: Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: A 12-month prospective study. J Rheumatol 1995;22:45–49.
14.
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Neri R, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE: Disease activity in systemic erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992;10:541–547.
15.
Breiman L, Friedman J, Olshen R, Stone C: Classification and Regression Trees. Pacific Grove, Wadsworth, 1984.
16.
Schwartz JE, Stone AA: Strategies for analyzing ecological momentary assessment data. Health Psychol 1998;17:6–16.
17.
House JS, Landis KR, Umberson D: Social relationships and health. Science 1988;241:540–545.
18.
Cohen S, Tyrrell DA, Smith AP: Psychological stress and susceptibility to the common cold. N Engl J Med 1991;325:606–656.
19.
Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM Jr: Social ties and susceptibility to the common cold. JAMA 1997;277:1940–1944.
20.
Schubert C, Lampe A, Rumpold G, Fuchs D, Konig P, Chamson E, Schussler G: Daily psychosocial stressors interfere with the dynamics of urine neopterin in a patient with systemic lupus erythematosus: an integrative single-case study. Psychosom Med 1999;61:876–882.
21.
Schubert C, Geser W, Noisternig B, König P, Rumpold G, Lampe A: Stressful life events and skin diseases: An additional perspective from research on psychosomatic dynamics in systemic lupus erythematosus. Psychother Psychosom 2002;71:123–124.
22.
Picardi A, Abeni D: Stressful life events and skin diseases: Disentangling evidence from myth. Psychother Psychosom 2001;70:118–136.
23.
Picardi A, Abeni D: Reply. Psychother Psychosom 2002;71:125–126.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.